心房颤动患者经皮冠状动脉支架置入术后抗栓策略  

Postoperative Antithrombotic Strategy for Patients with Atrial Fibrillation after Percutaneous Coronary Stent Implantation

作　　者：海静如[1] 黄学成[1] 

机构地区：[1]广西医科大学第三附属医院心血管内科,南宁530031

出　　处：《医学综述》2012年第12期1876-1879,共4页Medical Recapitulate

摘　　要：心房颤动(简称房颤)是临床最常见的心律失常之一,有极高的致残率及致死率。2010版的房颤治疗指南中抗栓治疗跃居其治疗总策略的第一位。房颤患者行冠状动脉支架置入术后针对不同抗栓机制的联合治疗策略是合理的,但目前很难把握好有效抗凝及出血风险的平衡点,需要根据个体化的实际情况,在术前严格评估患者术后的栓塞及出血风险,预见性地选择患者围术期及术后长期的持续抗栓方案。Atrial fibrillation is one of the most common clinical arrhythmias,which has a very high morbidity and mortality.Antithrombotic therapy in atrial fibrillation treatment guidelines of the 2010 edition had ranked the first of its treatment of the overall strategies.After the coronary stent implantation of patients with atrial fibrillation,combination therapy strategies according to different antithrombotic mechanisms is reasonable,however,it is difficult to grasp the balance point of effective anticoagulation and risk of bleeding.According to the actual situation of the individual,postoperative embolism and the risk of bleeding must be assessed strictly to make the forward-looking choice of perioperative and postoperative long-term sustained antithrombotic program.

关 键 词：心房颤动 冠心病 介入治疗 抗栓 

分 类 号：R541.7[医药卫生—心血管疾病]